Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-31trueNo description of principal activityfalse72024-07-08falsetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 15823906 2024-07-07 15823906 2024-07-08 2024-12-31 15823906 2023-07-08 2024-07-07 15823906 2024-12-31 15823906 c:Director8 2024-07-08 2024-12-31 15823906 d:CurrentFinancialInstruments 2024-12-31 15823906 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 15823906 d:ShareCapital 2024-12-31 15823906 d:RetainedEarningsAccumulatedLosses 2024-12-31 15823906 c:FRS102 2024-07-08 2024-12-31 15823906 c:AuditExempt-NoAccountantsReport 2024-07-08 2024-12-31 15823906 c:FullAccounts 2024-07-08 2024-12-31 15823906 c:PrivateLimitedCompanyLtd 2024-07-08 2024-12-31 15823906 e:PoundSterling 2024-07-08 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 15823906










ASI LONDON E CLINICIAN HOLDINGS LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 DECEMBER 2024

 
ASI LONDON E CLINICIAN HOLDINGS LIMITED
REGISTERED NUMBER: 15823906

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
Note
£

Fixed assets
  

Investments
 5 
4,584,017

  
4,584,017

Current assets
  

Debtors: amounts falling due within one year
 6 
7,010

  
7,010

Creditors: amounts falling due within one year
 7 
(2,040)

Net current assets
  
 
 
4,970

Total assets less current liabilities
  
4,588,987

  

Net assets
  
4,588,987


Capital and reserves
  

Called up share capital 
  
4,561,207

Profit and loss account
  
27,780

  
4,588,987


Page 1

 
ASI LONDON E CLINICIAN HOLDINGS LIMITED
REGISTERED NUMBER: 15823906
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




A Gupta
Director

Date: 19 December 2025

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
ASI LONDON E CLINICIAN HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

1.


General information

ASI London E Clinician Holdings Limited is a private company limited by shares incorporated in England and Wales in the United Kingdom. The address of the registered office is 6th Floor, 33 Wigmore Street, London, W1U 1QX.

The company was incorporated as a holding company on 8 July 2024, and commenced activity on that date. The first period of account is shorter than one year, so that the year end falls in line with that of the wider group. 

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.3

Associates and joint ventures

Associates and Joint Ventures are held at cost less impairment.

Page 3

 
ASI LONDON E CLINICIAN HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.4

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.5

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

3.


Judgements in applying accounting policies and key sources of estimation uncertainty

No significant judgements have been made by management in preparing these financial statements.


4.


Employees

The average monthly number of employees, including directors, during the period was 7.

Page 4

 
ASI LONDON E CLINICIAN HOLDINGS LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2024

5.


Fixed asset investments





Investments in associates

£



Cost or valuation


Additions
4,584,017



At 31 December 2024
4,584,017





6.


Debtors

2024
£


Amounts owed by group undertakings
7,010

7,010



7.


Creditors: Amounts falling due within one year

2024
£

Accruals and deferred income
2,040

2,040



8.


Parent undertaking

The parent undertaking is ASI London E Clinician LLP

 
Page 5